News & Updates
Filter by Specialty:

DOACs for ICH survivors with atrial fibrillation? Stroke protection comes at a cost
14 Feb 2025
byJairia Dela Cruz
For survivors of intracerebral haemorrhage (ICH) with atrial fibrillation (AF), the use of direct oral anticoagulants (DOACs) works to prevent ischaemic stroke events, but this benefit appears to be offset by major bleeding side effects, as shown in the open-label, phase III PRESTIGE-AF trial.
DOACs for ICH survivors with atrial fibrillation? Stroke protection comes at a cost
14 Feb 2025
COVID-linked MIS-C outcomes reassuring at 6 months
31 Jan 2025
byElvira Manzano
Children and young adults with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection show good cardiovascular and noncardiovascular outcomes at 6 months, according to data from the long-term MUSIC study.